Danial E. Baker
Impact in
- Gastroenterology top 5%
- Gastrointestinal motility and disorders
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Pharmaceutical studies and practices 26
- Pharmacological Effects and Toxicity Studies 20
- Epidemiology 45
- Pneumocystis jirovecii pneumonia detection and treatment 10
- Co-authors
- Terri Levien (133 shared papers)Dennis J. Cada (120 shared papers)R. Keith Campbell (15 shared papers)Stephen M. Setter (5 shared papers)George S. Jaresko (1 shared paper)Daniel C. Robinson (1 shared paper)John R. White (4 shared papers)Jack E. Fincham (1 shared paper)
- Journals
- Hospital Pharmacy (214 papers)Annals of Pharmacotherapy (7 papers)The Diabetes Educator (4 papers)American Journal of Health-System Pharmacy (3 papers)Clinical Therapeutics (3 papers)
- Partner nations
- United StatesFranceUnited Arab Emirates
In The Last Decade
Danial E. Baker
252 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 143
- Gastroenterology 81
- Endocrinology, Diabetes and Metabolism 244
- Hepatology 59
- Pharmacology 65
- Toxicology 25
Countries citing papers authored by Danial E. Baker
This map shows the geographic impact of Danial E. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danial E. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danial E. Baker more than expected).
Fields of papers citing papers by Danial E. Baker
This network shows the impact of papers produced by Danial E. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danial E. Baker. The network helps show where Danial E. Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Danial E. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 281 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 89 | |
| 2 | 2006 | 72 | |
| 3 | 1992 | 68 | |
| 4 | 2005 | 65 | |
| 5 | 2005 | 51 | |
| 6 | 2002 | 45 | |
| 7 | Rifaximin: a nonabsorbed oral antibiotic. | 2005 | 38 |
| 8 | Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C. | 2003 | 38 |
| 9 | Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody. | 2004 | 34 |
| 10 | 2013 | 33 | |
| 11 | 2001 | 29 | |
| 12 | Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum. | 2003 | 27 |
| 13 | 1992 | 22 | |
| 14 | Alendronate and risedronate: what you need to know about their upper gastrointestinal tract toxicity. | 2002 | 21 |
| 15 | 2001 | 20 | |
| 16 | The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. | 2004 | 20 |
| 17 | 2007 | 19 | |
| 18 | 2016 | 19 | |
| 19 | 2013 | 18 | |
| 20 | 2009 | 18 |
About Danial E. Baker
Danial E. Baker is a scholar working on Pediatrics, Perinatology and Child Health, Epidemiology, Surgery, Pharmacology and Infectious Diseases, having authored 281 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (26 papers), Pharmacological Effects and Toxicity Studies (20 papers), Diabetes Treatment and Management (16 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Hepatitis C virus research (12 papers), Diabetes Management and Research (12 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). The work is most often cited by research in Gastroenterology (81 citations), Endocrinology, Diabetes and Metabolism (244 citations), Hepatology (59 citations), Pharmacology (65 citations) and Toxicology (25 citations). Danial E. Baker has collaborated with scholars based in United States, France and United Arab Emirates. Frequent co-authors include Terri Levien, Dennis J. Cada, R. Keith Campbell, Stephen M. Setter, George S. Jaresko, Daniel C. Robinson, John R. White, Jack E. Fincham, Sunanda V. Kane and James B. Leonard. Their work appears in journals such as Hospital Pharmacy, Annals of Pharmacotherapy, The Diabetes Educator, American Journal of Health-System Pharmacy and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.